Efficacy and safety of linagliptin monotherapy in Asian patients with inadequately controlled type 2 diabetes mellitus: A multinational, 24-week, randomized, clinical trial

AIMS/INTRODUCTION: Asian patients represent a large portion of the global population with type 2 diabetes mellitus, but are underrepresented in trials of glucose-lowering therapies. The present randomized, phase III, placebo-controlled, double-blind, 24-week study evaluated the dipeptidyl peptidase-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Diabetes Investig
Main Authors: Chen, Yuhong, Ning, Guang, Wang, Changjiang, Gong, Yan, Patel, Sanjay, Zhang, Candice, Izumoto, Toshiyasu, Woerle, Hans-Juergen, Wang, Weiqing
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4627547/
https://ncbi.nlm.nih.gov/pubmed/26543544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12346
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados